Cleared Traditional

K133681 - CRUX SNARE FILTER RETRIEVAL SET

K133681 is the FDA 510(k) clearance for CRUX SNARE FILTER RETRIEVAL SET by Volcano Corporation. It is a Class 2 Cardiovascular device (product code MMX) cleared through the Traditional 510(k) pathway after a 59-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2014
Decision
59d
Days
Class 2
Risk

K133681 is an FDA 510(k) clearance for the CRUX SNARE FILTER RETRIEVAL SET. Classified as Device, Percutaneous Retrieval (product code MMX), Class II - Special Controls.

Submitted by Volcano Corporation (Billerica, US). The FDA issued a Cleared decision on January 30, 2014 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5150 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Volcano Corporation devices

Submission Details

510(k) Number K133681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 02, 2013
Decision Date January 30, 2014
Days to Decision 59 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 125d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MMX Device, Percutaneous Retrieval
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MMX Device, Percutaneous Retrieval

All 21
Devices cleared under the same product code (MMX) and FDA review panel - the closest regulatory comparables to K133681.
Recovery Cone Removal System
K152136 · C.R. Bard, Inc. · Feb 2016
EN Snare Endovascular Snare System
K151497 · Merit Medical Systems, Inc. · Jul 2015
ONE Snare Endovascular Microsnare System
K142265 · Merit Medical Systems, Inc. · Nov 2014
MERIT ONE SNARE SYSTEM
K122088 · Merit Medical Systems, Inc. · Dec 2012
FOURSNARE VASCULAR RETRIEVAL SNARE
K112185 · Cook, Inc. · Nov 2011
EN SNARE ENDOVASCULAR SNARE SYSTEM
K092343 · Merit Medical Systems, Inc. · Aug 2009